Article
BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer
7 Nov 2017
Abstract excerpt
Abstract Purpose: This study examined the potential role of the nuclear deubiquitinating enzyme BRCA1-associated protein-1 (BAP1) in radioresistance in head and neck squamous cell cancer (HNSCC). Experimental Design: We overexpressed, knocked down, and rescued BAP1 expression in six HNSCC cell lines, three human papillomavirus (HPV)–negative and three HPV-positive, and examined the effects on radiosensitivity in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
